シンバイオ製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4582/E24682 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/09/26 | 日証協 | 720,100株 | +6.6% | 80,100株 | +5.81% | 553,047株 | +7.67% | 23,400株 | -57.06% |
| 2014/09/19 | 日証協 | 675,500株 | +0.09% | 75,700株 | +20.54% | 513,647株 | -4.29% | 54,500株 | +86.64% |
| 2014/09/12 | 日証協 | 674,900株 | +4.51% | 62,800株 | +164.98% | 536,647株 | +5.19% | 29,200株 | -13.35% |
| 2014/09/05 | 日証協 | 645,800株 | +2.22% | 23,700株 | +200% | 510,147株 | +2.37% | 33,700株 | +501.79% |
| 2014/08/29 | 日証協 | 631,800株 | -0.85% | 7,900株 | -35.25% | 498,347株 | 0% | 5,600株 | +154.55% |
| 2014/08/22 | 日証協 | 637,200株 | -2.51% | 12,200株 | +1255.56% | 498,347株 | -2.45% | 2,200株 | -33.43% |
| 2014/08/15 | 日証協 | 653,600株 | 0% | 900株 | 0% | 510,847株 | +0.37% | 3,305株 | -43.98% |
| 2014/08/08 | 日証協 | 653,600株 | 0% | 900株 | -68.97% | 508,942株 | -1.32% | 5,900株 | -21.33% |
| 2014/08/01 | 日証協 | 653,600株 | 0% | 2,900株 | -76.42% | 515,742株 | +1.22% | 7,500株 | +212.5% |
| 2014/07/25 | 日証協 | 653,600株 | +1.21% | 12,300株 | -38.5% | 509,542株 | +0.73% | 2,400株 | -68.42% |
| 2014/07/18 | 日証協 | 645,800株 | -8.29% | 20,000株 | +45.99% | 505,842株 | -5.77% | 7,600株 | -55.29% |
| 2014/07/11 | 日証協 | 704,200株 | -28.95% | 13,700株 | -76.26% | 536,842株 | -33.38% | 17,000株 | -30.89% |
| 2014/07/04 | 日証協 | 991,100株 | +9.36% | 57,700株 | -22.96% | 805,842株 | +6.73% | 24,600株 | -58.87% |
| 2014/06/27 | 日証協 | 906,300株 | +2.66% | 74,900株 | -31.54% | 755,038株 | +2.18% | 59,812株 | +46.24% |
| 2014/06/20 | 日証協 | 882,800株 | +0.3% | 109,400株 | +335.44% | 738,939株 | -1.59% | 40,900株 | +330.44% |
| 2014/06/13 | 日証協 | 880,124株 | -16.81% | 25,124株 | +593.27% | 750,862株 | -9.89% | 9,502株 | -33.08% |
| 2014/06/06 | 日証協 | 1,058,024株 | -1.83% | 3,624株 | +81.2% | 833,262株 | -0.2% | 14,200株 | +255% |
| 2014/05/30 | 日証協 | 1,077,700株 | 0% | 2,000株 | -84.62% | 834,962株 | -0.13% | 4,000株 | +73.76% |
| 2014/05/23 | 日証協 | 1,077,700株 | +2.47% | 13,000株 | -37.8% | 836,062株 | -0.22% | 2,302株 | +35.73% |
※株式分割は考慮していませんのでご注意ください。
Page Top